Page last updated: 2024-08-24

cidofovir anhydrous and Communicable Diseases, Emerging

cidofovir anhydrous has been researched along with Communicable Diseases, Emerging in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damaso, CR; Jesus, DM; Moussatché, N1
Papavassiliou, VG; Pierroutsakos, IN; Vorou, RM1

Reviews

1 review(s) available for cidofovir anhydrous and Communicable Diseases, Emerging

ArticleYear
Cowpox virus infection: an emerging health threat.
    Current opinion in infectious diseases, 2008, Volume: 21, Issue:2

    Topics: Animals; Antiviral Agents; Cats; Cidofovir; Communicable Diseases, Emerging; Cowpox; Cowpox virus; Cytosine; Humans; Organophosphonates; Zoonoses

2008

Other Studies

1 other study(ies) available for cidofovir anhydrous and Communicable Diseases, Emerging

ArticleYear
In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:1

    Topics: Animals; Antiviral Agents; Brazil; Cattle; Cattle Diseases; Cell Line; Chlorocebus aethiops; Cidofovir; Communicable Diseases, Emerging; Cytosine; Disease Outbreaks; Humans; Kidney; Microbial Sensitivity Tests; Organophosphonates; Smallpox Vaccine; Vaccinia; Vaccinia virus; Virus Replication; Zoonoses

2009